Acrux

(OTC) ARUXF

Current Price$0.02

Market Cap$8.83M

Since IPO (2008)-98%

5 Year-84%

1 Year-58%

1 Month+276%

Acrux Financials at a Glance

Market Cap

$8.83M

Revenue (TTM)

A$3.61M

Net Income (TTM)

-A$8.34M

EPS (TTM)

-$0.00

P/E Ratio

-4.57

Dividend

$0.00

Beta (Volatility)

-0.67 (Low)

Dividend

$0.00

Beta (Volatility)

-0.67 (Low)

Price

$0.02

Volume

40,000

Open

$0.02

Price

$0.02

Volume

40,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Aug 21, 2026

Dividend

$0.00

Beta (Volatility)

-0.67 (Low)

Price

$0.02

Volume

40,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

Aug 21, 2026

ARUXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Acrux

Industry

Pharmaceuticals

Sector

Health Care

CEO

John Warmbrunn

Website

www.acrux.com.au

Headquarters

West Melbourne, VIC 3003, AU

ARUXF Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

-2%

Net Income Margin

-84%

Return on Equity

-102%

Return on Capital

-2%

Return on Assets

-50%

Earnings Yield

-21.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.83M

Shares Outstanding

522.28M

Volume

40.00K

Avg. Volume

1.73K

Financials (TTM)

Gross Profit

A$1.19M

Operating Income

-A$8.97M

EBITDA

-A$5.17M

Operating Cash Flow

-A$5.47M

Capital Expenditure

-A$5.00K

Free Cash Flow

-A$5.48M

Cash & ST Invst.

A$863.00K

Total Debt

A$3.64M

Acrux Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$1.74M

-60.6%

Gross Profit

A$1.52M

+166.7%

Gross Margin

87.24%

N/A

Market Cap

$8.83M

N/A

Market Cap/Employee

$205.27K

N/A

Employees

N/A

Net Income

A$164.93K

+105.1%

EBITDA

-A$1.07M

+73.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$945.63K

-79.3%

Total Debt

A$3.64M

+61.1%

Accounts Receivable

A$1.63M

-58.6%

Inventory

A$0.00

N/A

Long Term Debt

A$2.88M

-12.2%

Short Term Debt

A$755.70K

+147.8%

Return on Assets

-49.76%

N/A

Return on Invested Capital

-1.94%

N/A

Free Cash Flow

A$1.53M

+197.2%

Operating Cash Flow

A$1.53M

+207.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IBOGFUniversal Ibogaine Inc.

IBOGFUniversal Ibogaine Inc.$0.03+0.00%

ZLDAFZelira Therapeutics Limited

ZLDAFZelira Therapeutics Limited$0.35+0.00%

PKTXProtoKinetix, Incorporated

PKTXProtoKinetix, Incorporated$0.01+0.00%

AXIMAXIM Biotechnologies, Inc.

AXIMAXIM Biotechnologies, Inc.$0.01+0.00%

AGNPFAlgernon Pharmaceuticals Inc.

AGNPFAlgernon Pharmaceuticals Inc.$0.43+0.00%

SIGYSigyn Therapeutics, Inc.

SIGYSigyn Therapeutics, Inc.$0.04+0.00%

REPCFRepliCel Life Sciences Inc.

REPCFRepliCel Life Sciences Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

ASTSAST SpaceMobile

ASTSAST SpaceMobile$82.41-0.16%

KEELKeel Infrastructure

KEELKeel Infrastructure$5.59+0.01%

Questions About ARUXF

What is the current price of Acrux?

Acrux is trading at $0.02 per share.

What is the 52-week range for Acrux?

Over the past 52 weeks, Acrux has traded between $0.00 and $0.05.

How much debt does Acrux have?

As of the most recent reporting period, Acrux reported total debt of A$2.38M.

How much cash does Acrux have on hand?

Acrux reported A$565.57K in cash and cash equivalents in its most recent financial results.

What is Acrux’s dividend yield?

Acrux does not currently have a dividend yield.

Acrux

Acrux Financials at a Glance

ARUXF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Acrux

ARUXF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Acrux Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ARUXF

What is the current price of Acrux?

What is the 52-week range for Acrux?

How much debt does Acrux have?

How much cash does Acrux have on hand?

What is Acrux’s dividend yield?

Premium Investing Services